1. Home
  2. NXJ vs NMRA Comparison

NXJ vs NMRA Comparison

Compare NXJ & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New Jersey Qualified Municipal Fund

NXJ

Nuveen New Jersey Qualified Municipal Fund

N/A

Current Price

$12.02

Market Cap

503.5M

Sector

Finance

ML Signal

N/A

NMRA

Neumora Therapeutics Inc.

N/A

Current Price

$2.49

Market Cap

554.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NXJ
NMRA
Founded
1999
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
503.5M
554.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
NXJ
NMRA
Price
$12.02
$2.49
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$6.57
AVG Volume (30 Days)
90.7K
732.0K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
3.27%
N/A
EPS Growth
N/A
57.85
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.01
$0.62
52 Week High
$12.90
$3.65

Technical Indicators

Market Signals
Indicator
NXJ
NMRA
Relative Strength Index (RSI) 23.20 35.39
Support Level $11.22 $2.35
Resistance Level $12.76 $2.58
Average True Range (ATR) 0.08 0.19
MACD -0.03 -0.11
Stochastic Oscillator 6.12 5.86

Price Performance

Historical Comparison
NXJ
NMRA

About NXJ Nuveen New Jersey Qualified Municipal Fund

Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: